|Articles|September 19, 2022
SynForU™- HerCare: Empowering "HER" With Clinically Validated Probiotics
Author(s)Synbio
Vulvovaginal Candidiasis (VVC) affects 75% of reproductive-age women, it is especially common during pregnancy due to higher estrogen levels and glycogen content in vaginal secretions. The latest clinical study conducted in pregnant subjects showed that SynForU™-HerCare, Lactobacilli probiotics reduce vulvovaginal symptoms, decrease emotional stress, reduce impairment of daily activities attributed to the infection, and improve defecation times. Download the whitepaper to find out how clinically validated probiotics can promote women's wellness inside-out.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
Related Content
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
The paradox in supplement research
2
Filling a research gap: Omega-3 biomarkers and early-onset dementia
3
What does the latest research reveal about omega-3s and human health?
4
Head in the game: Choline, cognition support and the mental aspects of sporting excellence
5